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Abstract
Cytosolic sulfotransferases (SULTs) are mammalian enzymes that detoxify a wide variety of chemicals through the addition
of a sulfate group. Despite extensive research, the molecular basis for the broad specificity of SULTs is still not understood.
Here, structural, protein engineering and kinetic approaches were employed to obtain deep understanding of the molecular
basis for the broad specificity, catalytic activity and substrate inhibition of SULT1A1. We have determined five new
structures of SULT1A1 in complex with different acceptors, and utilized a directed evolution approach to generate SULT1A1
mutants with enhanced thermostability and increased catalytic activity. We found that active site plasticity enables binding
of different acceptors and identified dramatic structural changes in the SULT1A1 active site leading to the binding of a
second acceptor molecule in a conserved yet non-productive manner. Our combined approach highlights the dominant
role of SULT1A1 structural flexibility in controlling the specificity and activity of this enzyme.
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Introduction
The cytosolic sulfotransferase (SULTs) family catalyzes the
transfer of a sulfate group from the universal 39-phosphoadenosine
59-phosphosulfate (PAPS) donor to a wide variety of acceptor
molecules bearing a hydroxyl or an amine group [1,2,3].
Sulfonation results in inactivation of the majority of acceptors,
including neurotransmitters, steroid hormones and drugs, thus
modulating their biological activity and rendering the product
more soluble and readily excretable. Sulfonation thus provides a
line of defense by enabling the detoxification of a variety of
chemicals. In some cases, however, sulfonation results in the
metabolic activation of carcinogens and mutagens, while natural
polymorphism in SULT genes has been shown to be associated
with an increased risk for cancer [4].
In humans, 13 different SULT genes have been identified and
can be divided into four families, including SULT1, SULT2,
SULT4 and SULT6 [5,6]. Of these, the SULT1 family is the
largest and is responsible for the sulfonation of phenol, thyroid and
steroid hormones, as well as a variety of xenobiotics and known
drugs [7]. The SULT1 family can be further divided into an
additional 5 sub-families, each displaying distinct substrate
preference and overlapping substrate specificity. For example,
SULT1A1 [8] displays substrate preference for small phenolic
compounds, while SULT1E1 shows a preference for estrogen
acceptors [9]. Despite differences in substrate preference, a
considerable degree of structural homology exists between the
SULTs, highlighting the difficulties in understanding the molec-
ular basis for the broad specificity of these enzymes [7].
A prevalent phenomenon in sulfotransferase activity is partial
inhibition at high substrate concentrations. The X-ray structure of
SULT1A1 in complex with p-nitrophenol (pNP) revealed two pNP
molecules bound to the enzyme active site, suggesting that
substrate inhibition is due to a decreased rate of catalysis when
both pNP molecules are bound [10]. However, to understand the
structural changes leading to binding of a second acceptor
molecule to SULT1A1 in a non-catalytic mode, much more
detailed structural data is needed.
In this study, we examined the molecular basis for the broad
specificity and substrate inhibition of SULT1A1 using structural,
protein engineering and kinetic approaches. We determined five new
X-ray structures of SULT1A1, including that of SULT1A1 in
complex with the 39-phosphoadenosine 59-phosphate (PAP) donor
product and 3-cyano-7-hydroxycumarin (3CyC) or 2-naphthol
(2NAP) acceptors. These structures demonstrate the high plasticity of
the SULT1A1 active site in accommodating different types of acceptor
molecule. Our SULT1A1 structures in complex with one or two 3CyC
molecules provide new insights into the structural basis of SULT1A1
substrate inhibition. Comparison between the two structures shows a
dramatic movement of Phe247 allowing the exposure of a conserved
binding site for the second 3CyC molecule. Directed evolution of
SULT1A1 for enhanced thermostability and catalytic activity allowed
the identification of residues found on the protein surface and in the
vicinity of SULT1A1 active site, respectively, that play crucial roles in
controlling these SULT1A1 properties. Finally, we determined the
structure of the SULT1A1 D249G mutant that confers increased
activity towards pNP and 3CyC, to highlight the importance of
structural flexibility in tuning SULT1A1 transfer activity.
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To obtain detailed understanding of the molecular basis for the
broad substrate specificity of SULT1A1, we solved four crystal
structures of wild type (WT) SULT1A1 in complex with different
acceptors. We determined the structure of SULT1A1 in complex
with PAP alone (SULT1A1-PAP), with PAP and 3CyC
(SULT1A1-PAP-3CyC1 and SULT1A1-PAP-3CyC2) and with
PAP and 2NAP (SULT1A1-PAP-2NAP) to resolutions of 2.0–
2.7 A ˚ (Table S1 and S2). Our overall determined structures
resemble the typical a/b core fold of SULT1A1, comprising four
b-strands framed by two a-helices on either side [7,9,10] (Fig. 1A).
In all determined structures, as well as in previously described
SULT1A1 structures, the PAP moiety is located at the same
position in a catalytically competent manner with all binding site
residues oriented to minimize conformational freedom of the PAP
molecule (Fig. 1B) [10,11].
Acceptor binding site
The SULT1A1-PAP binary complex structure, in the absence
of acceptor, reveals a large L-shaped empty binding site proximate
to the PAP donor product (Fig. 1C). This empty site is very
similar to the binding site that is occupied by the different
acceptors (Fig. 1 and below), indicating that PAP binding leads to
the pre-formation of the acceptor binding pocket in SULT1A1.
The acceptor cavity can be divided into two compartments,
referred to as pocket-1 and pocket-2, formed by Phe24, Phe81,
Lys106, His108, Val148 and Phe247 (colored red mesh in Fig. 1C)
and by Phe76, Phe84, Ile89, Tyr240, and Phe247 (colored blue
mesh in Fig. 1C), respectively. We found that SULT1A1 crystals
formed only in the presence of PAP, suggesting that PAP binding
leads to dramatic conformational changes in the protein, as
observed in the case of the SULT1A3 structure [12,13].
The refined 3D structure of SULT1A1-PAP-2NAP revealed a
single 2NAP molecule within pocket-1, positioned in a catalytically
competent manner in which the hydroxyl group is positioned
2.34 A ˚ from the catalytic amine group of His108 and 3.33 A ˚ from
Lys106 (see Fig. 1D). The position of 2NAP is stabilized by
hydrogen bonding with a nearby water molecule, as well as by
stacking hydrophobic interactions with pocket-1 hydrophobic
residues.
We determined SULT1A1 structures in complex with PAP and
one or two molecules of the 3CyC acceptor (SULT1A1-PAP-
3CyC1 and SULT1A1-PAP-3CyC2, respectively). The SULT1A1-
Figure 1. The overall structure of SULT1A1-PAP and flexibility of the SULT1A1 binding pocket. (A) View of SULT1A1-PAP with the PAP
molecule colored in brown and the gating loop (residues 86–90) colored in blue. (B) Structural flexibility of SULT1A1 is demonstrated by the
overlapping of the donor and acceptor binding pockets of all newly and previously determined SULT1A1 structures (see text for details). The colors of
the gating loop, the donor and the acceptors are as follows: SULT1A1-PAP-2NAP-pink, SULT1A1-PAP-green, SULT1A1-PAP-3CyC2-orange, SULT1A1-
PAP-pNP-blue (PDB code 1LS6), SULT1A1-PAP-E2-red (PDB code 2D06) (C) SULT1A1 in complex with PAP shows the formation of a SULT1A1 empty
acceptor binding site comprising pocket-1 and pocket-2, depicted as red and blue mesh blobs, respectively. (D) The structure of SULT1A1-PAP-2NAP.
The 2NAP acceptor and PAP donor are colored in pink and the 2NAP is outlined with a FO-FC electron omit map contoured at 2.5o ´. Key residues in
panels C and D are colored red.
doi:10.1371/journal.pone.0026794.g001
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to increased 3CyC concentration. These structures allowed us to
examine the changes undergone by SULT1A1 upon binding of one
versus two 3CyC molecules. In the SULT1A1-PAP-3CyC2
structure, the first 3CyC molecule (3CyC1) is located in a
catalytically competent position with its first phenol ring fitting in
between Phe142 and Phe81 in pocket-1, and its hydroxyl group
forming hydrogen bonds with the catalytic His108 and Lys106
residues (Fig. 2A). The second 3CyC molecule, 3CyC2, is stacked
between Phe76 and Phe84 at a 90u degree planar rotation in
relation to 3CyC-1 (Fig. 2A). The SULT1A1-PAP-3CyC1
structure, containing only one 3CyC acceptor (Fig. 2B), demon-
strates similar features to the SULT1A1-PAP-3CyC2 structure,
although several important differences exist. The most prominent
difference was identified at Phe247, which is flipped 100u towards
pocket-1 in a similar manner as seen in the SULT1A1-PAP and
SULT1A1-PAP-2NAP structures (Fig. 2C). The location of
Phe247 leads to a vertical shift in the position of the 3CyC phenol
ring by 28.7u. Phe247 is thus partially stabilized by a p-p interaction
between the cyanide group of 3CyC and Phe247 and by hydrogen
bonding to the Phe247 carbonyl (distance 3.76 A ˚; Fig. 2B). The
flexibility of 3CyC-1 in pocket-1, affecting Phe247, can lead to the
binding of a second 3CyC molecule to pocket-2, thereby affecting
the catalytic efficiency of sulfate transfer (Fig. 2C). However, it is
possible that 3CyC-2 binding is leading to conformational changes
in the SULT1A1 active site affecting Phe247.
Comparing the different SULT1A1 structures
Comparing the four newly determined structures of WT
SULT1A1 together with the previously determined structures
SULT1A1-PAP-pNP and SULT1A1-PAP-E2 [10,11] enabled us to
explore conformational changes induced by the binding of diverse
acceptors to SULT1A1 (Fig. 3 and Table S3). Identified changes
among the different structures were exclusively mapped to those
residues shaping pocket-1, representing the catalytically competent
binding site (Fig. 1C). The most prominent changes were identified
at residues 86–90, corresponding to the gating loop (Fig. 1B). The
gating loop dictates the pocket entrance width and can thus control
the entryand evacuation of non-sulfonated and sulfonated molecules,
respectively (Fig. 3). Comparing the root mean square deviation
(RMSD) values of the SULT1A1-PAP structure gating loop with that
of SULT1A1-PAP-2NAP, SULT1A1-PAP-3CyC1, SULT1A1-
PAP-pNP, SULT1A1-PAP-3CyC2 and SULT1A1-PAP-E2 demon-
strated significant differences (1.08, 1.28, 1.4, 1.57 and 2.04 A ˚,
respectively) which correlated with a gradual withdrawal of the loop
towards the solvent (Fig. 1B). Comparing the dimension properties
of the acceptor pockets (i.e., cavity volume, pore area and pore width)
among the different structures reveals a general correlation between a
withdrawal of the gating loop and an increase in the volume of the
cavity (Fig. 1 and Table S3), illustrating the plasticity of the binding
site to accommodate diverse acceptors.
Comparing the structures of SULT1A1-PAP-2NAP and
SULT1A1-PAP-3CyC1 (Fig. S1) reveals that the binding of a
Figure 2. The molecular basis of SULT1A1 3CyC substrate inhibition. Structure of SULT1A1 in complex with PAP and two molecules of 3CyC
(SULT1A1-PAP-3CyC2, A) or one molecule of 3CyC (SULT1A1-PAP-3CyC1, B) bound at the acceptor-binding site. Key residues are highlighted in red
and the 3CyC molecules are outlined with FO-FC electron omit maps contoured at 2.5o ´. (C) Superposition of 3CyC molecules and key residues within
the SULT1A1-PAP-3CyC1 and SULT1A1-PAP-3CyC2 structures indicating dramatic movements of the 3CyC cyano group and of Phe247.
doi:10.1371/journal.pone.0026794.g002
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leads to inward movement of the gating loop. This, in turn,
dramatically decreases the distance between Ile89 and Phe76 (3.84
versus 6.60 A ˚ in SULT1A1-PAP-2NAP and SULT1A1-PAP-
3CyC1, respectively), compacting pocket-2 and the entrance to the
pore (see Fig. S1 and Table S3). It thus appears that the
hydrophobic nature of 2NAP is sufficient to create additional
hydrophobic interactions with Phe84 and Phe247 that drive the
closure of the binding pocket in such a way that deflects any
additional 2NAP molecules from entering the non-catalytic
pocket.
Directed evolution of SULT1A1
To obtain a deeper understanding of the structure-function
relationship of SULT1A1, we employed a directed evolution
approach to obtain SULT1A1 mutants showing enhanced
thermostability and catalytic activity (Fig. S2). The directed
evolution approach involves two major steps: (i) the generation of
genetic diversity in the gene of interest to obtain large mutant
libraries and (ii) the selection of these libraries for the desired
catalytic or binding activity [15,16,17]. As a first step in the
evolution of SULT1A1 for novel specificity, we sought to improve
SULT thermostability. It was previously shown that highly
thermostable enzymes that readily express in E. coli serve as an
excellent starting point for further directed evolution efforts aiming
for enhanced catalytic activity and novel specificity [18]. In
addition, a trade-off was observed between thermostability and
change in enzyme catalytic activity [18]. Thus, mutations that can
alter SULT1A1 catalytic properties can lead to reduced
thermostability and expression of active protein in E. coli.
Generation of SULT1A1 gene libraries
An effective approach for generating gene libraries that are
highly enriched in thermostable mutants involves the targeted
mutagenesis of residues that deviate from the consensus sequence
of the family back to the consensus sequence [19]. To identify such
residues, 34 mammalian SULT1 sequences, corresponding to 8
SULT1A1 homologues, were aligned. Comparison of the SULT
sequences revealed that 13 different positions in human SULT1A1
deviate from the consensus sequence (Table S4). These residues
were thus targeted by mutagenesis. We incorporated the ‘back-to-
consensus’ mutations into SULT1A1 using the ISOR (Incorpora-
tion of Synthetic Nucleotide via Gene Reassembly [20])
methodology for partial mutagenesis of the targeted positions.
Following library generation, sequencing of 10 random SULT1A1
library variants revealed an average of 6 ‘back-to-consensus’
mutations per gene. Each library variant carried a random, and
different, subset of mutated residues, with the entire set being
represented in the library (data not shown).
Screening of the ‘back-to-consensus’ library for enhanced
thermostability
To isolate SULT1A1 mutants with enhanced thermostability
from the ‘back-to-consensus’ library described above, we have
developed a simple and rapid high-throughput screening meth-
odology for assessing the transfer of sulfate to 3CyC (Fig. S2). This
screening assay, performed using E. coli crude cell lysates
expressing the mutant library clones, follows the quenching of
3CyC fluorescence upon sulfate transfer. We screened ,600
different mutants from the library for sulfate transfer (SULT) to
3CyC activity by following the time-dependent decrease in the
3CyC fluorescent signal. The top 45 of the SULT1A1 variants
exhibiting WT or increased SULT activity were further challenged
by heat inactivation at 50uC for 15 min and the residual sulfate
transfer activity to 3CyC was measured. These conditions
significantly reduced the activity of the WT protein and thus,
were optimal for identifying thermostable SULT1A1 mutants.
The 10 mutants exhibiting the highest thermostability were
sequenced. We found combinations of all of the ‘back-to-
consensus’ mutations in the selected SULT1A1 mutants (Table
S5). This indicates that such mutations are either neutral or
beneficial for the catalytic activity and thermostability of the
mutants. Selected mutants were over-expressed in E. coli cells and
purified using Ni-NTA affinity chromatography. Examination of
Figure 3. Surface representation of the binding pocket and pore size of the different SULT1A1 structures. Ligands and binding pockets
are colored according to the displayed SULT1A1 structure: SULT1A1 in complex with PAP and 2NAP (A, pink), PAP (B, green), PAP and 3CyC1
(C, containing one 3CyC molecule, orange), PAP and 3CyC2 (D, containing two 3CyC molecules, grey), PAP and pNP (E, blue) or PAP and E2 (F, red).
Key residues are highlighted in stick-form. Newly determined structures are A–D.
doi:10.1371/journal.pone.0026794.g003
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prolonged incubation at different temperatures revealed an up to
7uC improvement in the heat-inactivation temperature, relative to
WT SULT1A1 (Fig. 4 and Table 1). Mapping the ‘back-to-
consensus’ mutations on the SULT1A1-PAP crystal structure
revealed that many of the mutations are scattered on the outer
surface of the protein (Fig. S3). Some of the mutations were
characterized by a substitution of hydrophobic residues with
charged residues (Table S5), resulting in reduced hydrophobicity
of the surface and promotion of electrostatic interactions with the
solvent. However, due to the large number of mutations, it is
difficult to dissect the contribution of each mutation to the overall
thermostability. Still, it is clear that enhanced thermostability is
attained by diverse contributions from the ‘back-to-consensus’
mutations.
Screening and isolation of SULT1A1 mutants with
enhanced catalytic activity
To select for SULT1A1 mutants with increased catalytic
activity, we employed genes encoding the 10 most highly
thermostable versions SULT1A1 as template for the generation
of a random mutant library. Next, we screened ,700 mutants for
SULT-mediated modification of the pNP and 3CyC acceptors at
100 mM and 10 mM, respectively (see Material and Methods for
details). Due to the low KM of SULT1A1 for pNP [10,21] the
screening assay should lead to the isolation of mutants with
increase in maximal velocity rather than a decrease in KM for this
substrate (see below). Using the screening assay, we identified
several mutants with substantially increased catalytic activity to
these acceptors, including the Y240C and D249G, mutations
located in a loop region in the vicinity of the SULT1A1 acceptor-
binding site (Table 1 and Figs. 5 and 6). To further characterize
the effects of these specific mutations, we generated Y240C and
the D249G single mutants on the background of WT SULT1A1
through site-directed mutagenesis. We found that the Y240C
mutant is prone to aggregation even at room temperature. As
such, this mutant was not further analyzed.
To characterize the thermostability and catalytic activity of the
evolved SULT1A1 mutants, we over-expressed the mutants in E.
coli cells and purified the proteins by affinity chromatography. We
found that the mutants displayed lower thermostability, relative to
the first generation of highly stable precursor mutants, yet were
more stable than the WT protein (Table 1 and Fig. 4). In
agreement with these results, the D249G point mutant exhibited
lower stability, relative to the WT parent protein (Fig. 4). These
results highlight the trade-off between the acquisition of increased
catalytic activity and thermostability. Next, the catalytic activity of
the WT protein and different mutants with the pNP and 3CyC
acceptors was measured using steady state kinetics. The kinetic
analysis of the evolved SULT1A1 mutants with pNP showed the
characteristic increase in SULT1A1 activity at low pNP
concentrations and inhibition at high substrate concentrations
[10,21] (Fig. 5, Table 2). The evolved SULT1A1 5F8 and 5C2
mutants (Table 2), as well as the D249G mutant, exhibited similar
or lower catalytic efficiency (ks, Table 2) but significantly increase
in the maximum velocity (Vp) relative to the WT enzyme
(Table 2). Hence, our data together with previous analysis of
the WT enzyme using colorimetric and radioactive assays [21,22]
indicate that the mutations in these evolved mutants led to
increased catalytic activity at high pNP concentrations but
reduced affinity to the first and second pNP molecules occupying
the SULT1A1 active site. Due to the low KM of WT SULT1A1 to
pNP [21,22] and the relatively low sensitivity of our non-
radioactive assay, we could not monitor the activity of WT
SULT1A1 at low pNP concentrations.
In contrast, kinetic analysis of the activity towards 3CyC
indicated no inhibition at high substrate concentrations for the
WT and the mutant proteins. WT SULT1A1 exhibited a much
higher KM of ,20 mM for 3CyC, relative to the pNP, in
accordance with the role of SULT1A1 in the sulfonation of small
phenolic substrates [8]. The evolved mutants, as well as the
D249G point mutant, exhibit higher KM values, relative to the
WT protein, and no saturation at concentrations up to 400 mM
3CyC (Fig. 5). Overall, the 5C2, 5F8 and D249G mutants exhibit
increased sulfate transfer activity to pNP and 3CyC at high
substrate concentrations and reduced affinity for these acceptors.
Structural analysis of SULT1A1 D249G mutant
To obtain deeper understanding of the structural differences
between the D249G mutant and the WT protein, we determined
the structure of the D249G mutant in complex with PAP and pNP
(D249G-PAP-pNP). Comparing the mutant to the previously
determined SULT1A1-PAP-pNP structure [10] indicates high
structural similarity, with calculated RMSD values of the total
atoms of 0.89A ˚ (Fig. 6A). However, we found significant local
structural changes in the vicinity of the D249G mutation. The
substitution of aspartic acid by glycine leads to a loss of hydrogen
bonding with Ser251 and possible destabilization of the loop
(Fig. 6). This destabilization can further disrupt and break the
interaction between His250 and the facing carbonyl of Tyr240 by
swiveling the His by 100u toward the solvent, as exemplified by the
presence of an additional rotamer (Fig. 6). Comparison of many
SULTs structures shows that the interaction between His250 and
the carbonyl of Tyr 240 is conserved in the majority of SULTs,
highlighting the importance of this interaction in controlling loop
stability (Fig. S4). This loss of connection may increase the
flexibility of the SULT1A1 binding site, leading to decreased
affinity for pNP and 3CyC molecules (Fig. 6). It should be noted
that the density surrounding the naturally occurring His250
rotamer is stronger than that of the alternative rotamer. We thus
assume that in the current crystal packing, this is the ruling
Figure 4. Heat inactivation curves for the WT SULT1A1 protein
and the 5C2, 5F8 and D249G SULT1A1 mutants. The 1E8 mutant
was isolated after the first round of evolution for increased
thermostability and the 5F8 was isolated after the second round of
evolution for increased catalytic activity. The decrease in stability of the
5F8 mutant, relative to 1E8, and the D249G mutant, relative to the WT
protein, highlight the trade-off between thermostability and the
acquisition of new catalytic properties (see text for details).
doi:10.1371/journal.pone.0026794.g004
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the binding pocket (Fig. 6). As this phenomenon was not observed
in any of the structures of WT SULT1A1 in complex with
different acceptors, the importance of Asp249 to the stabilization
of the loop and consequently, to the stabilization of Tyr240 within
the catalytic pocket, is further supported.
Discussion
In this work, we employed structural, protein engineering and
kinetic approaches to gain detailed understanding of the molecular
basis for the broad specificity of SULT1A1. The determination of
four new structures of SULT1A1 in complex with the PAP donor and
different acceptors enabled us to monitor conformational changes in
SULT1A1 upon binding of diverse acceptors. Our results, providing
snapshots of SULT1A1 in complex with different acceptors, thus
allows us to follow the gradual changes in binding site volume and
gating loop movement that occur upon acceptor binding (Fig. 1 and
Fig. 3). These results agree with previous structural analysis of
different SULT structures determined in complex with different
acceptors, demonstrating the high plasticity of the SULT enzyme
family [7]. The analysis of the SULT1A1 binary complex with PAP
showed that this flexible bindingpocketispreformed in the absenceof
acceptors. Such ‘priming’ was previously shown for various SULTs
and suggests ordered binding in SULT1A1, whereby binding of
PAPS precedes that of the acceptor [7]. In contrast, it was shown that
in the case of SULT2A1, the donor and acceptors can bind
independently and that the binding of the acceptor does not
necessarily prime the donor binding site [7].
A common characteristic of SULT activity is inhibition at high
substrate concentrations. Elegant structural and kinetic character-
ization of SULT1A1 with pNP indicated two pNP molecules
bound at the active site, albeit in different binding modes [10]. It
was shown that one pNP molecule is bound in a catalytic mode
while the other is bound at a non-catalytic site, probably leading to
substrate inhibition [10]. Our determined SULT1A1 structures in
complex with one or two 3CyC acceptor molecules indicate that
the formation of the binding site for the second 3CyC molecule
(3Cyc-2) is probably induced upon binding of the first molecule to
the enzyme active site. Comparing the two structures suggests that
subtle movements of the 3CyC-1 in the active site leads to
substantial movement of Phe247, leading to the exposure of the
second 3CyC-binding site (Fig. 2). However, it is possible that the
binding of the second 3CyC molecule leads to this movement of
Phe247. Our kinetic analysis of WT SULT1A1 with 3CyC does
not reveal inhibition at 3CyC concentrations of up to 400 mM,
indicating that sulfate transfer at these acceptor concentrations
Table 1. Mutations and heat inactivation temperatures
a of newly evolved SULT1A1 variants.
SULT1A1 variants Mutations Heat inactivation temperatures
a
WT - 42.360.1
1E8 (R1) Q56E, A101S, T117S, Q177K, M223I, V243L 48.160.1
1E9 (R1) L67V, A101S, Q177K, V211L, F222K, F247I 48.360.4
5F8 (R2)
b Q56E, A101S, T117S, H213R, F222L, V243L, T266N, L111P, Y240C 44.760.1
5C2 (R2)
b Q56E, L67V, A101S, T117S, H213R, F222L, V243I D249G 43.360.3
D249G
c D249G 39.360.2
aHeat inactivation temperatures were measured by testing SULT1A1 residual activity following incubation at different temperatures (see Fig. 4 and Material and
Methods).
bMutations inserted by random mutagenesis in the second round of evolution are highlighted in bold (see text).
cThe D249G mutation was generated on the background of the WT protein.
doi:10.1371/journal.pone.0026794.t001
Figure 5. Kinetic analysis of the sulfate transfer activity of the
WT SULT1A1 protein and the 5C2, 5F8 and D249G SULT1A1
mutants to pNP (A) and 3CyC (B). Each data point represents the
mean of three independent experiments. The lines in A represent fit to
data obtained with pNP of equation 1 (see Material and Methods)
adopted from ref. 21, taking into account the inhibition seen at high
pNP concentrations. The lines in B represent fit to Michaelis-Menten
equation of data obtained with 3CyC or linear fit to data obtained at
low 3CyC concentrations (inset). The kcat/KM parameters derived from
the fits are 1208, 466, 149 and 308 for the WT, 5C2, 5F8 and D249G,
respectively, presented as sec
21 M
21.
doi:10.1371/journal.pone.0026794.g005
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non-productive mode. In contrast, our crystallization efforts
performed with SULT1A1 together with 3CyC at high concen-
tration of 1000 mM, yielding crystals of SULT1A1 in complex
with one or two 3CyC molecules. These structures, together with
the SULT1A1 structure in complex with pNP, indicate a common
mechanism for substrate inhibition in SULT1A1 in which a
similar binding site is formed at high acceptor concentrations to
allow the binding of a second acceptor molecule. Our results are
also in correlation with previous studies showing that the
SULT1A1 F247L mutation presents substrate inhibition by
dopamine, revealing the importance of Phe247 in controlling
SULT1A1 substrate inhibition [21]. Interestingly, flipping of the
Phe247 was previously identified in SULT1A1 upon binding of
estradiol in a non-catalytic orientation [10,11]. In contrast, it was
shown that upon binding of two pNP molecules in SULT1A1 the
Phe247 is not flipped [10]. These structures together with the
structures described in this study shows that the movement of
Phe247 is probably dependent on the acceptor size and is not
obligatory to allow the binding of a second acceptor molecule in
SULT active site.
To provide further insight into the molecular basis of SULT1A1
catalytic activity, we utilized a directed evolution approach.
Accordingly, we first generated highly stable SULT1A1 mutants
by insertion of ‘back-to-consensus’ mutations, followed by random
mutagenesis to isolate mutants with higher catalytic activity than
the WT enzyme. We found that increased SULT1A1 thermosta-
bility was probably the result of several stabilizing mutations,
rather than being due to one global suppressor, as is the case with
the TEM1 b-lactamase M182T mutation [19,23]. The SULTA1
Figure 6. Comparison of the SULT1A1 and SULT1A1-D249G structures in complex with PAP and pNP. (A) Structural superposition of
SULT1A1 (PDB code 1LS6, light blue) and SULT1A1-D249G mutant (gold). (B–C) View of SULT1A1 (B) and the SULT1A1-D249G mutant (C) ligand
pocket and the stabilizing loop containing Asp249 or Gly249 (rotamers are indicated with superscript). SULT1A1-D249G key residues and pNP
molecule are outlined with a 2FO-FC electron density map contoured at 1.6o ´.
doi:10.1371/journal.pone.0026794.g006
Table 2. Kinetic parameters of SULT1A1 wild-type and newly
evolved 5C2, 5F8 and D249G mutants with pNP and 3CyC.
SULT1A1 pNP 3CyC
ks
a
sec
21 M
21
Vp
a
nmol/min/mg
V‘
a
nmol/min/mg
kcat/KM
c
sec
21 M
21
WT
b 12857 92.5 - 1208
5C2 47836175 441628 165628 466
5F8 135916466 393618 174610 149
D249G 106756233 259662 6 633 0 8
aKinetic parameters for sulfate transfer to pNP were determined by fitting the
experimental data to the equation described in ref 21 (see also Material and
Methods), taking into account the inhibition observed at high pNP
concentrations. The parameter ks is the specificity constant at low pNP
concentrations and is equivalent to kcat/KM in Michaelis-Menten kinetics. Vp is
the rate at the peak and V‘ is the limiting rate when pNP reaches ‘ (Fig. 5).
bThe WT parameters for pNP are adapted from Alcombri et al.[22] the kcat/KM is
equivalent to ks and Vmax is equivalent to Vp.
cThe kcat/KM values for 3CyC are derived from the fit to Michaelis-Menten
equation of data obtained with 3CyC for the WT or linear fit to data obtained at
low 3CyC concentrations for the different mutants (Fig. 5).
doi:10.1371/journal.pone.0026794.t002
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7uC increase in heat inactivation temperature, can buffer the
deleterious effects of additional mutations, leading to increased
activity. This trade-off between stability and the acquisition of new
function has been previously reported for several enzymes [18]. It
was previously shown that stabilized P450 and TEM1 mutants
exhibithigherevolvabilityupontheintroductionofa largevarietyof
mutations without substantial disruption of the native folding of
these proteins [19,24]. We found that two mutations, namely
D249G and Y240C, both located in the vicinity of the active site,
can lead to substantial increases in catalytic activity with 3CyC and
pNP at high substrate concentrations but lower affinity for these
substrates. Structural analysis of the D249G mutant reveals an
increase in the local flexibility of this region, resulting in a dramatic
movement of His250 that can affect the SULT1A1 active site. The
structural conservation of the His250 in many different SULT
structures (Fig. S4) may highlight the importance of this region for
controlling SULT catalytic activity. It is possible that the higher
flexibility allows higher substrate turnover but reduces affinity due
to changes in the active site. In accordance, electrostatic surface
potential analysis of the D249G mutant relative to the WT enzyme
indicates a dramatic change incharge distribution aroundthe active
site (Fig. S5). These changes can lead to reduced affinity for the
different acceptors due to possible differences in acceptor binding or
effects on the dynamics and flexibility of SULT1A1.
In summary, our work provides new insight into the molecular
basis for the broad specificity of SULT1A1 and highlights the
importance of structural flexibility for the recognition of a variety
of substrates and for controlling SULT1A1 catalytic properties.
The use of structural, engineering and kinetic approaches as
employed here can be highly beneficial for understanding the
molecular basis for the broad specificity of many other liver
enzymes that can detoxify a wide variety of substrates, including
amidases, monooxygenases, and other transferases.
Materials and Methods
Crystallization conditions, diffraction measurements and
structural determination
All crystallization conditions and statistics for the five new
SULT1A1 crystal structures are provided in Tables S1 and S2.
Grown crystals were mounted in cryoloops at 2180uC and
collected X-ray diffraction data sets were reduced and scaled using
the HKL2000 suite (SULT1A1-PAP and SULT1A1-PAP-2NAP)
[25] or iMosflm and Scala (SULT1A1(D249G)-PAP-pNP and
SULT1A1-PAP-3CyC) [26,27]. Phases were obtained by molec-
ular replacement with Phaser [28] using the human SULT1A1
structure (PDB code 1LS6) for our diffraction data [10]. Molecular
replacement solutions were followed by rigid body refinement,
restrained refinement (Refmac5 software package) [29] and
manual building (Coot [30]).
Least-square overlaps and volume calculation
Structural superposition was performed by the SwissPDB viewer
alternate domain fitting function [31]. Ligand pocket volume
calculations were established by subtracting the molecular surface
of protein complexed with donor and acceptor from the molecular
surface of protein complexed with donor alone. The cavity volume
of the SULT1A1-PAP-2NAP structure was directly calculated by
the software. The cavity volume of the SULT1A1-PAP structure
was calculated by the inclusion of two pNP molecules according to
their location by superimposing 1LS6 on the structure of
SULT1A1-PAP. The cavity volume of the total SULT1A1-PAP-
3CyC2 structure was calculated by inclusion of molecule 3CyC2
from the SULT1A1-PAP-3CyC1 structure.
Calculation of electrostatic potential and binding pocket
cavity
Electrostatic calculations were performed by PyMOL [32] using the
Adaptive Poisson-Boltzmann Solver (APBS) plug-in [33]. The ligand
binding pockets of the hSULT1A1-PAP structure were calculated with
the Hollow program [34], setting the solvent-accessible surface around
the binding pocket to a probe radius of 1.4 A ˚.
Plasmids and bacterial strains
The E. coli DH5a and Clooni (Lucigen) strains were used for
cloning. The E. coli BL21 (DE3) strain was used for protein
expression and purification. Human cDNA was used as template
for amplification of the human SULT1A1 gene. The amplified
gene was cloned into bacterial vector pET32tr (a version of pET32
(Novagen) with truncated thioredoxin) using the NdeI and XhoI
sites.
Synthetic shuffling
SULT1A1 amino acid sequences from eight mammalian species
were aligned using Muscle software (EMBL-EBI). Oligo-nucleo-
tides used for synthetic shuffling were 31–33 bases long and
contained the ‘back-to-consensus’ single mutation flanked by 15
bases complementary to the SULT1A1 gene at both ends. The
SULT1A1 gene was PCR amplified and 6–10 mg of the PCR
products were digested by DNaseI. Fragments (approximate size,
80–120 bp) were extracted and purified. To incorporate the
oligonucleotides, the purified fragments were mixed with 5–10 nM
of the oligonucleotides and subjected to assembly PCR. The
products of the assembly PCR were directly used as template for
the amplification of the full length SULT1A1 library containing
the spiked oligonucleotides, digested with NdeI and XhoI and
cloned into the pET32tr vector as described above.
Random mutagenesis
Target SULT1A1 sequences were randomly mutagenized by
PCR performed with mutagenic dNTP analogs [35]. Mutagenesis
stringency was controlled by the number of PCR cycles performed
and dNTPs analogs concentration [35].
Library expression and screening
Single E. coli BL21 (DE3) colonies transformed with library or
control plasmids were picked to inoculate 600 ml LB media
containing 100 mg/ml ampicillin in 96 deep-well plates (Nunc).
The plates were incubated with shaking at 37uC overnight. The
cells were diluted 1:50 in fresh selective LB media, incubated with
shaking at 37uC until an OD600 of 0.4–0.6 and induced with
0.1 mM of IPTG (Calbiochem). The plates were incubated with
shaking at 30uC for an additional 5 h and centrifuged at 4000 rpm
for 15 min. Media was discarded and the cells were resuspended
in 150 ml lysis buffer (2.5 mM MgCl2, 0.5 mM CaCl2, 0.2%
Triton X-100, 2 U/ml DNaseI (NEB), 1 mg/ml lysozyme, 20 mM
HEPES, pH 7.5). The plates were incubated with shaking at 37uC
for 30 min, followed by 15 min of centrifugation at 4000 rpm.
The supernatant (120 ml) was transferred to 96 V shaped-well
plates (Nunc) and stored at 4uC for analysis (see sulfotransferase
activity assay, below).
Protein expression and purification
Single colonies were picked to inoculate 5 ml of LB media
containing ampicillin (100 ml/ml) and were grown for 16 h at 37uC,
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0.1 mM IPTG (Calbiochem) for an additional 18 h at 20uC. Cells
were harvested and centrifuged for 10 min at 6000 g, resuspended
in 30 ml 20 mM HEPES, pH 7.5, and recentrifuged for 20 min.
Following centrifugation, cells were resuspended in 10 ml/g of
binding buffer (1 M NaCl, 40 mM imidazole, 1 mg/ml lysozyme,
20 mM HEPES, pH 7.4). Next, the cells were lysed by sonication,
centrifuged and the cleared supernatant was loaded on a pre-
equilibrated column containing 2 ml Ni-NTA resin (Qiagen).
Following incubation, the resin was washed and SULT1A1 was
eluted in 1 ml fractions upon addition of elution buffer. Fractions
containing SULT1A1 were analyzed by SDS-PAGE, pooled and
dialyzed for 16 h against storage buffer (40 mM HEPES, pH 7.5,
7 mM MgCl2, 1.5 mM DTT and 20% glycerol) at 4uC. Protein
concentration was determined with a BCA protein assay kit (Pierce).
Wash and elution buffers were based on 500 mM NaCl, 20 mM
HEPES,pH 7.4andsupplemented withimidazole,accordingtothe
manufacturer’s recommendations.
Sulfotransferase activity assays
Clear lysates or purified proteins were added to a reaction mix
consisting of the pNP or 3CyC acceptors at different concentrations,
1 mM PAPS, 20 mM HEPES, pH 7.5, 7 mM MgCl2,a n d1 . 5m M
DTT to a final volume of 200 ml .T h ed e c r e a s ei na b s o r b a n c e
(405 nm and 408 nm for pNP and 3CyC, respectively) or
fluorescence (3CyC, 408 nm excitation and 450 nm emission) was
monitored every15–40 sec,for atleast 20 min, using an ELISAplate
reader (Infinite-200, Tecan). Screening of the SULT1A1 library for
mutants with increased catalytic efficiency or altered specificity was
performed using pNP and 3CyC at 10 mMand10 0mM,respectively.
Analysis of the kinetic data obtained with pNP was performed
according to ref. 21 by fitting the data to the following equation:
v=(ks[S]+V‘[S]
2/Ks
2)/(1+[S]
2/Ks
2) (equation 1) using SigmaPlot
software. The parameter ks is the specificity constant at low pNP
concentrations and is equivalent to kcat/KM in Michaelis-Menten
kinetics. Vp i st h er a t ea tt h ep e a ka n dV ‘ is the limiting rate when
pNP reaches ‘. Analysis of the kinetic data obtained with 3CyC was
performed by fitting the data to the Michaelis-Menten equation or to
a linear equation. For heat inactivation analysis, the clear lysates or
the purified protein were incubated for 15 min at the desired
temperature using a DNA Engine Peltier Thermal Cycler (Bio-Rad)
and then assayed as described above.
Supporting Information
Figure S1 Comparison of SULT1A1 structures in com-
plex with PAP and 2NAP or 3CyC. Superposition of the gating
loop and keyresiduesindicateaclosureofthe gating loop,leadingto
a smaller cavity volume (see main text and Table S3 for details).
(TIF)
Figure S2 Scheme describing the directed evolution
process and the acceptors used for the analysis of
SULT1A1 specificity. (A) The directed evolution process for the
generation of SULT1A1 mutants with increased thermostability
(R1) and specificity (R2). (B–D) Acceptors used for the directed
evolution process of SULT1A1 were pNP (B), 3CyC (C).
(TIF)
Figure S3 Surface representation model of the human
SULT1A1 structure in complex with PAP. The surface
mutations identified in thermostable SULT1A1 mutants (Table 1
and Table S3) are highlighted in blue. The model was generated
using the Swiss PDB viewer program.
(TIF)
Figure S4 Comparison of SULT structures highlighting
the loop region containing Tyr240, Asp249, Ser251 and
His250. The high extent of overlap between the loop location
and residues demonstrates the structural conservation of this
region. In the SULT1A1 D249G mutant, His250 flips about 100u
degrees towards the solvent, leading to the loss of interaction
between His250 and the carbonyl of Tyr240. The structures that
are overlapped are: WT human SULT1A1 in complex with PAP
(1A1 w.t., light green), the SULT1A1 D249G mutant in complex
with PAP and pNP (1A1 mutant, orange), human SULT1C2 in
complex with PAP (1C2, magenta, PDB code 2GWH), mouse
SULT1D1 in complex with PAP (1D1, blue, PDB code 2ZYT),
human SULT1B1 in complex with PAP and resveratol (1B1, dark
orange, PDB code 3CKL), human SULT1C3 in complex with
PAP (1C3, dark green, PDB code 2HK8), and human SULT1A2
in complex with PAP (1A2, yellow, PDB code 1Z29).
(TIF)
Figure S5 Electrostatic surface representation of
SULT1A1 and SULT1A1-D249G showing a dramatic
change in the surface electrostatics of the two proteins.
Changes in the electrostatics of the surface can affect the pNP
acceptor binding site that is located in the vicinity of Asp249. The
approximate locations of Asp249 or G249 and the pNP2 molecule
are highlighted by arrows.
(TIF)
Table S1 Crystallographic statistics of SULT1A1 structures.
(DOC)
Table S2 Crystallization conditions for SULT1A1.
(DOC)
Table S3 Comparison of SULT1A1 pore size and cavity
volume.
(DOC)
Table S4 Amino acids in human SULT1A1 that deviate from
the family consensus: Comparison to SULT1A1 and SULT1
families.
(DOC)
Table S5 Mutation distribution in SULT1A1 thermostable
mutants.
(DOC)
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